IP Library Granted Patent US 8,076,451
Granted Patent B2
US 8,076,451 · App. 11/778,323 · Granted Dec 13, 2011

Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide

Assignees: Board of Governors for Higher Education, State of Rhode Island and Providence Plantations; Yale University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,076,451
App. No.
11/778,323
Granted
Dec 13, 2011
Kind
B2
Abstract

A polypeptide with a predominantly hydrophobic sequence long enough to span a membrane lipid bilayer as a transmembrane helix (TM) and comprising one or more dissociable groups inserts across a membrane spontaneously in a pH-dependant fashion placing one terminus inside cell. The polypeptide conjugated with various functional moieties delivers and accumulates them at cell membrane with low extracellular pH. The functional moiety conjugated with polypeptide terminus placed inside cell are translocated through the cell membrane in cytosol. The peptide and its variants or non-peptide analogs can be used to deliver therapeutic, prophylactic, diagnostic, imaging, gene regulation, cell regulation, or immunologic agents to or inside of cells in vitro or in vivo in tissue at low extracellular pH. The claimed method provides a new approach for diagnostic and treatment diseases with naturally occurred (or artificially created) low pH extracellular environment such as tumors, infarction, stroke, atherosclerosis, inflammation, infection, or trauma. The method allows to translocate cell impermeable molecules (peptides, toxins, drugs, inhibitors, nucleic acids, peptide nucleic acids, imaging probes) into cells at low pH. The method allows to attach to the cell surface a variety of functional moieties and particles including peptides, polysaccharides, virus, antigens, liposomes and nanoparticles made of any materials.

Claims (17)

1. A purified peptide comprising SEQ ID NO:1.

2. A conjugate comprising a compound covalently bound to an amino-terminal residue or a carboxy-terminal residue of a peptide comprising SEQ ID NO:1, wherein said compound comprises a therapeutic, diagnostic, prophylactic, imaging, gene regulation, cell function regulation, or apoptotic compound.

3. The conjugate of claim 2 , wherein said therapeutic compound comprises a cytotoxic molecule.

4. The conjugate of claim 2 , wherein said diagnostic compound comprises a fluorescent molecule.

5. The peptide of claim 1 , wherein said peptide further comprises a Cys residue at the amino-terminus of SEQ ID NO:1.

6. A conjugate comprising a compound covalently bound to the Cys residue of the peptide of claim 1 , wherein said compound comprises a therapeutic, diagnostic, imaging, gene regulation, cell function regulation, or apoptotic compound.

7. A conjugate comprising a compound covalently bound to the Cys residue at the amino terminus of the peptide of claim 5 , wherein said compound comprises a therapeutic, diagnostic, imaging, gene regulation, cell function regulation, or apoptotic compound.

8. The conjugate of claim 6 , wherein said therapeutic compound comprises a cytotoxic molecule.

9. The conjugate of claim 6 , wherein said diagnostic compound comprises a fluorescent molecule.

10. The conjugate of claim 7 , wherein said therapeutic compound comprises a cytotoxic molecule.

11. The conjugate of claim 7 , wherein said diagnostic compound comprises a fluorescent molecule.

12. A peptide in which one or more L-amino acids in SEQ ID NO:1 is substituted with a corresponding D-isomer.

13. The peptide claim 1 or 5 , wherein said peptide comprises L-amino acids.

14. The peptide claim 6 or 7 , wherein said peptide comprises L-amino acids.

15. A peptide comprising SEQ ID NO:1 and further comprising a Cys residue at the amino-terminus of SEQ ID NO:1, wherein one or more L-amino acids in the peptide is substituted with a corresponding D-isomer.

16. A conjugate comprising a compound covalently bound to the Cys residue of SEQ ID NO:1, wherein said compound comprises a therapeutic, diagnostic, imaging, gene regulation, cell function regulation, or apoptotic compound and wherein one or more L-amino acids in SEQ ID NO:1 is substituted with a corresponding D-isomer.

17. A conjugate comprising the peptide of claim 15 and a compound covalently bound to the Cys residue at the amino-terminus of the peptide, wherein said compound comprises a therapeutic, diagnostic, imaging, gene regulation, cell function regulation, or apoptotic compound.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2021
From: RHODE ISLAND COUNCIL ON POSTSECONDARY EDUCATION
To: UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES
Reel/Frame 056228/0626 →
CHANGE OF NAME Recorded May 12, 2021
From: RESHETNYAK, YANA K.; ANDREEV, OLEG A.; LEHNERT, URSULA; ENGELMAN, DONALD M.
To: RHODE ISLAND COUNCIL ON POSTSECONDARY EDUCATION
Reel/Frame 056211/0678 →
CONFIRMATORY LICENSE Recorded Jan 19, 2012
From: UNIVERSITY OF RHODE ISLAND
To: US ARMY, SECRETARY OF THE ARMY
Reel/Frame 027557/0443 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2010
From: BOARD OF GOVERNORS FOR HIGHER EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS
To: YALE UNIVERSITY
Reel/Frame 024885/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 12, 2010
From: BOARD OF GOVERNORS FOR HIGHER EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS
To: YALE UNIVERSITY
Reel/Frame 024830/0768 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2008
From: RESHETNYAK, YANA K.; ANDREEV, OLEG A.; LEHNERT, URSULA; ENGELMANN, DONALD M.
To: BOARD OF GOVERNORS FOR HIGHER EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS
Reel/Frame 020939/0501 →
Continuity (4)
Continuation PCTUS2006001895 · Jan 18, 2006
Provisional Application 60752238 · Dec 20, 2005
Provisional Application 60644654 · Jan 18, 2005
Related Publication 20080233107A1 · Sep 25, 2008